Literature DB >> 21063923

High incidence and frequency of LOH are associated with aggressive features of high-grade HER2 and triple-negative breast cancers.

Eriko Tokunaga1, Satoko Okada, Nami Yamashita, Sayuri Akiyoshi, Hiroyuki Kitao, Masaru Morita, Yoshihiro Kakeji, Yoshihiko Maehara.   

Abstract

BACKGROUND: Basal-like and HER2-overexpressing breast carcinomas are histologically undifferentiated, high-grade tumors with a high proliferation rate and associated with a poor outcome. Most basal-like tumors lack the expression of ER, PR, and HER2 (triple-negative; TN). Loss of heterozygosity (LOH) is thought to reflect random chromosomal instability, and recent studies have shown that DNA-copy number alterations or LOH occur with a high frequency in basal-like and HER2-amplified tumors.
METHODS: The levels and patterns of LOH were analyzed by the microsatellite alteration analysis using fluorescence-labeled primers and an automated DNA sequencer at 5 randomly selected loci in 246 Japanese primary breast cancers. Associations between the level of LOH and breast cancer subtypes and tumor aggressiveness were investigated.
RESULTS: The incidence and frequency of LOH was significantly higher in HER2 (56.3, 26.7%) and TN groups (44.4, 27.1%) than in luminal A (ER-positive and/or PR-positive and HER2-negative) groups (32.0, 12.2%). The incidence and frequency of LOH increased as nuclear grade was elevated. There were significantly more grade 3 tumors in the HER2 (80.0%) and TN (68.2%) subgroups (p < 0.0001). Even in HER2 and TN cases, the incidence and frequency of LOH was significantly higher in nuclear grade 3 cases than in grade 1 or 2 cases. Relapse-free survival of patients with LOH was significantly shorter than for those without LOH. In addition, the survival time was shorter as the frequency of LOH elevated. The incidence of LOH was an independent prognostic factor for relapse-free survival by multivariate analysis.
CONCLUSION: High incidence and frequency of LOH, which indicate increased genetic instability, were found to be associated with the aggressive features of high-grade HER2 and TN breast cancers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21063923     DOI: 10.1007/s12282-010-0232-7

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  5 in total

1.  Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.

Authors:  Raphael Richard; Isabelle Thomassin; Marion Chapellier; Aurélie Scemama; Patricia de Cremoux; Mariana Varna; Sylvie Giacchetti; Marc Espié; Eric de Kerviler; Cedric de Bazelaire
Journal:  Eur Radiol       Date:  2013-05-08       Impact factor: 5.315

2.  Analysis of genome instability in breast cancer.

Authors:  Eldamária de Vargas Wolfgramm; Lyvia Neves Rebello Alves; Elaine Stur; Thaís Tristão Tovar; Mariana Penha De Nadai Sartori; Allan Kardec de Castro Neto; Iúri Drumond Louro
Journal:  Mol Biol Rep       Date:  2012-11-27       Impact factor: 2.316

3.  Oncogene-triggered suppression of DNA repair leads to DNA instability in cancer.

Authors:  Julia A Yaglom; Christopher McFarland; Leonid Mirny; Michael Y Sherman
Journal:  Oncotarget       Date:  2014-09-30

4.  Genomic instability at the 13q31 locus and somatic mtDNA mutation in the D-loop site correlate with tumor aggressiveness in sporadic Brazilian breast cancer cases.

Authors:  Gilson Costa dos Santos; Andréa Carla de Souza Góes; Humberto de Vitto; Carla Cristina Moreira; Elizabeth Avvad; Franklin David Rumjanek; Claudia Vitoria de Moura Gallo
Journal:  Clinics (Sao Paulo)       Date:  2012-10       Impact factor: 2.365

5.  Loss of Estrogen Receptors is Associated with Increased Tumor Aggression in Laryngeal Squamous Cell Carcinoma.

Authors:  Anjali Verma; Nofrat Schwartz; David J Cohen; Vaidehi Patel; Benny Nageris; Gideon Bachar; Barbara D Boyan; Zvi Schwartz
Journal:  Sci Rep       Date:  2020-03-06       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.